小鼠模型研究:天冬酰胺合酶积累导致Angelman综合征脑生长迟缓
Buildup of normally harmless enzyme stunts brain growth in mice with Angelman syndrome
华盛顿大学医学中心团队在小鼠中证实,Angelman综合征中UBE3A基因缺失导致天冬酰胺合酶积累,进而触发脑内错误应激反应,造成脑生长受阻。该研究发表于Nature,发现抑制天冬酰胺合酶生成可恢复小鼠正常脑发育。目前仍需进一步探索该酶触发应激的具体机制及最佳干预时机。
Angelman syndrome is a rare disease with a single known cause: one missing gene. The lack of that gene, normally inherited from the mother, occurs in approximately one in 20,000 births and is associated with cognitive and mobility deficits that become evident in children when they are around 6 months old.
While the cause of the syndrome seems simple, it is not well understood why the absence of the gene has the effects that it does. That has made treatments for the condition elusive.
An enzyme buildup disrupts brain growth
New research from Jason Yi, an assistant professor of neuroscience at Washington University School of Medicine in St. Louis, has found in mice that the missing gene is the first domino in a biological sequence that leads to a normally harmless enzyme accumulating in the brain. The buildup is not harmful on its own but appears to have indirect effects that ultimately impair brain growth.
The study was published Oct. 21 in Nature.
"The neurons are tricked into thinking that they're in stress when they're not—that's bad because they will then not grow normally," Yi said, noting that most children with Angelman syndrome have smaller brains than do their peers of the same age. "It's a reaction from the brain trying to conserve resources to protect itself. It does suggest that there is a dysregulation in the brain we might be able to correct."
Indeed, Yi's team found that righting one of the downstream dominoes in the molecular cascade of Angelman syndrome reestablished healthy brain development and behaviors in mice.
The findings mark the first time that an increase in this enzyme—asparagine synthetase—has been linked to a neurological condition. The finding adds to a growing body of scientific evidence that protein imbalances, even when they aren't directly damaging cells, can trigger stress responses that can lead to neurodevelopmental disorders.
Tracing the missing gene's effects
The path from the missing gene in Angelman syndrome to the stress response is not direct. The gene, called UBE3A, produces an enzyme called ubiquitin ligase, a housekeeping protein that marks unneeded proteins in cells for disposal. Ubiquitin ligase is active throughout the brain and is involved in 60 different cellular processes.
To narrow down which of those 60 were related to Angelman syndrome, Yi and his team developed modified cells in the lab in which the UBE3A gene was deactivated.
In these experiments, they identified 23 candidate proteins that increased in the absence of the gene. Of these, one had a strong link to ubiquitin ligase's normal housekeeping function: asparagine synthetase. This is yet another enzyme that helps cells produce essential proteins.
Yi and his colleagues showed in mice that were genetically modified to develop Angelman syndrome that elevated levels of asparagine synthetase activated the brain's stress response. The finding was surprising because the enzyme does not interact with normal triggers for the stress response and because the overabundance of the enzyme does not otherwise damage the cell.
This stress response leads to a dramatic reduction in protein production and growth as the brain tries to conserve resources.
When Yi and his team blocked the production of asparagine synthetase, they found that normal brain growth was restored.
Treatment targets need further investigation
Yi said the stress response triggered by asparagine synthetase could be targeted by medications, but much remains to be learned before work on a possible treatment can begin.
The team is working to further characterize precisely why asparagine synthetase triggers the brain's stress response and to map where in the brain the stress response is most active and when during development medical interventions would be most effective.
"We still don't know a whole lot about the disease," said Yi. "We haven't been able to identify all of the things that the missing gene is doing and rescue the things that it is not doing in Angelman syndrome. But I think our data are the most complete so far to begin answering those questions."
Publication details
Jason Yi, Persistent neuronal stress signalling underlies Angelman syndrome phenotypes, Nature (2026). DOI: 10.1038/s41586-026-11165-4. www.nature.com/articles/s41586-026-11165-4
Journal information: Nature
Who's behind this story?
Swati Mestri
Swati Mestri holds a bachelor's degree in Electronics Engineering and has worked as a content editor since 2019. She has experience editing research documents across technology, health care, and materials science, and has a particular interest in technology and space. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Buildup of normally harmless enzyme stunts brain growth in mice with Angelman syndrome (2026, October 21) retrieved 21 October 2026 from https://medicalxpress.com/news/2026-10-buildup-harmless-enzyme-stunts-brain.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com